Stability of Pain-Related Medications / Metabolites / Illicit Substances in Urine
Analytical Considerations When Monitoring Pain Meds by LC-MS / MS
Evaluation of High-Resolution Mass Spectrometry for Urine Toxicology
Medication / Illicit Substance Use Analyzed Using LC-MS / MS
Illicit Drug Use Correlates with Negative UDT Results / Prescribed Medications
Interpretation of Urine Drug Testing in Pain Patients
Dilute and shoot analysis of drugs of abuse using selected reaction
Relationship between the concentration of hydrocodone
Observations on the urine metabolic ratio of oxymorphone to oxycodone
Evaluating the relationship between carisoprodol concentrations
Observations of the metabolism of morphine to hydromorphone
Evaluating the relationship of methadone concentrations
Improvement of pain physicians’ practices of opioid management
Therapeutic monitoring of benzodiazepines in the management of pain
3 things to consider before relying solely on point of care tests
Millennium Research Institute Publications List
Improved detection of ethyl glucuronide and ethyl sulfate
Laffer Associates Economic Cost/Benefit Paper
Ethyl glucuronide, ethyl sulfate, and ethanol in urine
Anomalous observations of hydrocodone in patients on oxycodone
Determination of illicit drug cutoff values in a pain patient population
Determination of medication cutoff values in a pain patient
Illicit drug use in the pain patient population decreases
Diagnostic accuracy and interpretation of urine drug testing
Drugs of abuse testing and therapeutic drug monitoring
An improved method of determining ethanol use in a chronic
Comparison of clonazepam compliance by measurement
Observations of medication compliance by measurement
Drug and drug metabolism excretion patterns in the chronic pain
Reference intervals: A novel approach to detect drug abuse in a pain patient population
Marijuana correlates with use of other illicit drugs
Monitoring of patients on chronic opioid therapy
An evaluation of the diagnostic accuracy of liquid chromatograph
A tale of two drug testing technologies: GC-MS and LC-MS/MS
Variability of transdermal fentanyl metabolism and excretion
Anomalous observations of codeine in patients on morphine
LC-MS/MS extends the range of drug analysis in pain patients
6-Acetylmorphine detected in the absence of morphine
Unstable propoxyphene metabolite excreted in human urine
